{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,2]],"date-time":"2025-11-02T10:26:22Z","timestamp":1762079182843},"reference-count":23,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2009,8,1]],"date-time":"2009-08-01T00:00:00Z","timestamp":1249084800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Epilepsy &amp; Behavior"],"published-print":{"date-parts":[[2009,8]]},"DOI":"10.1016\/j.yebeh.2009.06.021","type":"journal-article","created":{"date-parts":[[2009,7,30]],"date-time":"2009-07-30T11:07:12Z","timestamp":1248952032000},"page":"506-512","source":"Crossref","is-referenced-by-count":11,"title":["A multicenter, outpatient, open-label study to evaluate the dosing, effectiveness, and safety of topiramate as monotherapy in the treatment of epilepsy in clinical practice"],"prefix":"10.1016","volume":"15","author":[{"given":"Raman","family":"Sankar","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eugene","family":"Ramsay","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Amy","family":"McKay","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joseph","family":"Hulihan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Frank","family":"Wiegand","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.yebeh.2009.06.021_bib1","unstructured":"WHO. Epilepsy, <http:\/\/www.who.int\/mental_health\/neurology\/epilepsy\/en\/print.html>; 2007 [accessed September 2007]."},{"key":"10.1016\/j.yebeh.2009.06.021_bib2","unstructured":"Epilepsy Foundation. Epilepsy and seizure statistics, <http:\/\/www.epilepsyfoundation.org\/about\/statistics.cfm>; 2007 [accessed September 2007]."},{"key":"10.1016\/j.yebeh.2009.06.021_bib3","unstructured":"WHO. Epilepsy: Aetiology, epidemiology, and prognosis, <http:\/\/www.who.int\/mediacentre\/factsheets\/fs165\/en\/>; 2007 [accessed September 2007]."},{"issue":"Suppl. 5","key":"10.1016\/j.yebeh.2009.06.021_bib4","doi-asserted-by":"crossref","first-page":"S9","DOI":"10.1212\/WNL.58.8_suppl_5.S9","article-title":"Optimizing health outcomes in active epilepsy","volume":"58","author":"Gilliam","year":"2002","journal-title":"Neurology"},{"key":"10.1016\/j.yebeh.2009.06.021_bib5","doi-asserted-by":"crossref","first-page":"1255","DOI":"10.1046\/j.1528-1157.2001.04501.x","article-title":"Effectiveness of first antiepileptic drug","volume":"10","author":"Kwan","year":"2001","journal-title":"Epilepsia"},{"key":"10.1016\/j.yebeh.2009.06.021_bib6","doi-asserted-by":"crossref","first-page":"1926","DOI":"10.1111\/j.1528-1167.2005.00341.x","article-title":"Pregabalin add-on treatment in patients with partial seizures: a novel evaluation of flexible-dose and fixed-dose treatment in a double-blind, placebo-controlled study","volume":"46","author":"Elger","year":"2005","journal-title":"Epilepsia"},{"key":"10.1016\/j.yebeh.2009.06.021_bib7","doi-asserted-by":"crossref","first-page":"1252","DOI":"10.1212\/01.WNL.0000123693.82339.FC","article-title":"Efficacy and tolerability of the new antiepileptic drugs: I. Treatment of new onset epilepsy","volume":"62","author":"French","year":"2004","journal-title":"Neurology"},{"key":"10.1016\/j.yebeh.2009.06.021_bib8","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1111\/j.1600-0404.2005.00485.x","article-title":"For the EPMN-106\/INT-28 Investigators. Randomized dose-controlled study of topiramate as first-line therapy in epilepsy","volume":"112","author":"Arroyo","year":"2005","journal-title":"Acta Neurol Scand"},{"key":"10.1016\/j.yebeh.2009.06.021_bib9","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1212\/01.WNL.0000048200.12663.BC","article-title":"A dose-comparison trial of topiramate as monotherapy in recently diagnosed partial epilepsy","volume":"60","author":"Gilliam","year":"2003","journal-title":"Neurology"},{"key":"10.1016\/j.yebeh.2009.06.021_bib10","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1034\/j.1600-0404.2003.00093.x","article-title":"Topiramate, carbamazepine and valproate monotherapy: double-blind comparison in newly diagnosed epilepsy","volume":"107","author":"Privitera","year":"2003","journal-title":"Acta Neurol Scand"},{"key":"10.1016\/j.yebeh.2009.06.021_bib11","doi-asserted-by":"crossref","first-page":"1180","DOI":"10.1111\/j.1528-1167.2008.01584.x","article-title":"Topiramate in older patients with partial-onset seizures: a pilot double-blind, dose-comparison study","volume":"49","author":"Ramsay","year":"2008","journal-title":"Epilepsia"},{"key":"10.1016\/j.yebeh.2009.06.021_bib12","doi-asserted-by":"crossref","first-page":"1094","DOI":"10.1111\/j.1528-1167.2006.00585.x","article-title":"ILAE treatment guidelines: evidence-based analysis of antiepileptic drug efficacy and effectiveness as initial monotherapy for epileptic seizures and syndromes","volume":"47","author":"Glauser","year":"2006","journal-title":"Epilepsia"},{"key":"10.1016\/j.yebeh.2009.06.021_bib13","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1002\/1531-8249(200012)48:6<833::AID-ANA3>3.0.CO;2-U","article-title":"Factors predicting prognosis of epilepsy after presentation with seizures","volume":"48","author":"MacDonald","year":"2000","journal-title":"Ann Neurol"},{"key":"10.1016\/j.yebeh.2009.06.021_bib14","doi-asserted-by":"crossref","first-page":"930","DOI":"10.1111\/j.1528-1157.1993.tb02114.x","article-title":"Remission of seizures and predictors of intractability in long-term follow-up","volume":"34","author":"Sillanp\u00e4\u00e4","year":"1993","journal-title":"Epilepsia"},{"key":"10.1016\/j.yebeh.2009.06.021_bib15","doi-asserted-by":"crossref","unstructured":"Collaborative Group for the Study of Epilepsy. Prognosis of epilepsy in newly referred patients: a multicenter prospective study of the effects of monotherapy on the long-term course of epilepsy. Epilepsia 1992;33:45\u201351.","DOI":"10.1111\/j.1528-1157.1992.tb02281.x"},{"key":"10.1016\/j.yebeh.2009.06.021_bib16","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1056\/NEJM200002033420503","article-title":"Early identification of refractory epilepsy","volume":"342","author":"Kwan","year":"2000","journal-title":"N Engl J Med"},{"key":"10.1016\/j.yebeh.2009.06.021_bib17","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1111\/j.1528-1157.1987.tb03633.x","article-title":"Early treatment and prognosis of epilepsy","volume":"28","author":"Reynolds","year":"1987","journal-title":"Epilepsia"},{"key":"10.1016\/j.yebeh.2009.06.021_bib18","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1136\/bmj.310.6973.176","article-title":"Controversies in management: do anticonvulsants alter the natural course of epilepsy? Treatment should be started as early as possible","volume":"310","author":"Reynolds","year":"1995","journal-title":"Br Med J"},{"key":"10.1016\/j.yebeh.2009.06.021_bib19","doi-asserted-by":"crossref","first-page":"952","DOI":"10.1016\/S0140-6736(83)90462-2","article-title":"Why does epilepsy become intractable? Prevention of chronic epilepsy","volume":"332","author":"Reynolds","year":"1983","journal-title":"Lancet"},{"key":"10.1016\/j.yebeh.2009.06.021_bib20","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1097\/00004691-199703000-00003","article-title":"Do seizures beget seizures? An assessment of the clinical evidence in humans","volume":"14","author":"Berg","year":"1997","journal-title":"J Clin Neurophysiol"},{"key":"10.1016\/j.yebeh.2009.06.021_bib21","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1136\/bmj.314.7078.401","article-title":"Clinical course of untreated tonic\u2013clonic seizures in childhood: prospective, hospital based study","volume":"314","author":"Von Donselaar","year":"1997","journal-title":"Br Med J"},{"key":"10.1016\/j.yebeh.2009.06.021_bib22","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1016\/j.seizure.2006.06.003","article-title":"Adherence to treatment in patients with epilepsy: associations with seizure control and illness beliefs","volume":"15","author":"Jones","year":"2006","journal-title":"Seizure"},{"key":"10.1016\/j.yebeh.2009.06.021_bib23","first-page":"647","article-title":"Non-compliance with pharmacological treatment in patients with epilepsy","volume":"42","author":"Enriquez-Caceres","year":"2006","journal-title":"Rev Neurol"}],"container-title":["Epilepsy &amp; Behavior"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1525505009003230?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1525505009003230?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,5,21]],"date-time":"2019-05-21T15:57:45Z","timestamp":1558454265000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1525505009003230"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,8]]},"references-count":23,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2009,8]]}},"alternative-id":["S1525505009003230"],"URL":"https:\/\/doi.org\/10.1016\/j.yebeh.2009.06.021","relation":{},"ISSN":["1525-5050"],"issn-type":[{"value":"1525-5050","type":"print"}],"subject":[],"published":{"date-parts":[[2009,8]]}}}